SJS Investment Consulting’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.73K | Sell |
6
-3
| -33% | -$863 | ﹤0.01% | 624 |
|
|
2025
Q1 | $2.78K | Hold |
9
| – | – | ﹤0.01% | 603 |
|
|
2024
Q4 | $3.18K | Sell |
9
-2
| -18% | -$706 | ﹤0.01% | 547 |
|
|
2024
Q3 | $3.94K | Hold |
11
| – | – | ﹤0.01% | 543 |
|
|
2024
Q2 | $3.51K | Hold |
11
| – | – | ﹤0.01% | 520 |
|
|
2024
Q1 | $2.53K | Sell |
11
-2
| -15% | -$459 | ﹤0.01% | 650 |
|
|
2023
Q4 | $2.86K | Hold |
13
| – | – | ﹤0.01% | 531 |
|
|
2023
Q3 | $2.94K | Buy |
13
+2
| +18% | +$452 | ﹤0.01% | 487 |
|
|
2023
Q2 | $2.43K | Buy |
11
+6
| +120% | +$1.33K | ﹤0.01% | 531 |
|
|
2023
Q1 | $1.12K | Sell |
5
-11
| -69% | -$2.46K | ﹤0.01% | 847 |
|
|
2022
Q4 | $4.45K | Buy |
16
+7
| +78% | +$1.95K | ﹤0.01% | 380 |
|
|
2022
Q3 | $2K | Buy |
+9
| New | +$2K | ﹤0.01% | 550 |
|
|
2022
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1350 |
|